Memantine in Systemic Lupus Erythematosus

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Memantine

Dispensing initially 5 mg. Dose Increased by 5 mg weekly to 20 mg/d final dose by week 4.

DRUG

Placebo

Dispensing initially 5 mg. Dose Increased by 5 mg weekly to 20 mg/d final dose by week 4

Trial Locations (1)

21205

Johns Hopkins Lupus Center, 1830 East Monument Street, Suite 7500, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00181298 - Memantine in Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter